PDE4B and acute lymphoblastic leukemia: In conclusion, PDE4B overexpression abrogates cAMP inhibition of cell proliferation (Ahlström et al., 2005; Zhao et al., 2016), providing theoretical support for clinical application in the treatment of ALL.